Paclitaxel Protein Bound Particles Albumin Bound Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0517-4300

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein Bound Particles Albumin Bound (NDC 0517-4300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Paclitaxel Protein Bound Particles For Injectable 1)

FDA Label Image

Structural Formula (Paclitaxel Protein Bound Particles For Injectable 2)

FDA Label Image

Figure 1 (Paclitaxel Protein Bound Particles For Injectable 3)

FDA Label Image

Paclitaxel Vial Label (Paclitaxel Protein Bound Particles For Injectable 4)

FDA Label Image

Printed Carton (Paclitaxel Protein Bound Particles For Injectable 5)

This is a description of a medication called Paclitaxel Protein-Bound Particles for Injectable Suspension. The medication comes in a single-dose vial with 100mg per vial. It is manufactured by MG RGOV and is for intravenous use only. The medication needs to be reconstituted with 20mL of 0.9% Sodium Chloride Injection. It is important to discard any unused portion. The medication helps in cancer treatment.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.